Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016—results from three population surveys
Summary Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non‐allergic asthma, is lacking. Objec...
Saved in:
| Published in | Clinical and experimental allergy Vol. 47; no. 11; pp. 1426 - 1435 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
01.11.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0954-7894 1365-2222 1365-2222 |
| DOI | 10.1111/cea.12963 |
Cover
Loading…
| Abstract | Summary
Background
During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non‐allergic asthma, is lacking.
Objective
The aim was to estimate prevalence trends of current asthma among adults, both allergic and non‐allergic, from 1996 to 2016.
Methods
Three cross‐sectional samples from the same area of Sweden, 20‐69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino‐conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.
Results
The prevalence of current asthma increased from 8.4% (95% CI: 7.8‐9.0) in 1996 to 9.9% (95% CI: 9.2‐10.6) in 2006 and 10.9% (95% CI: 10.1‐11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5‐5.5) in 1996 to 6.0% (95% CI: 5.4‐6.6) in 2006 and further to 7.3% (95% CI: 6.6‐8.0) in 2016 (P<.001), while the prevalence of non‐allergic asthma remained stable around 3.4%‐3.8%. The increase in current asthma was most pronounced among women and among the middle‐aged. Physician‐diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.
Conclusions and Clinical Relevance
The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non‐allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. |
|---|---|
| AbstractList | During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.
The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.
Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.
The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.
The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. Summary Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non‐allergic asthma, is lacking. Objective The aim was to estimate prevalence trends of current asthma among adults, both allergic and non‐allergic, from 1996 to 2016. Methods Three cross‐sectional samples from the same area of Sweden, 20‐69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino‐conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma. Results The prevalence of current asthma increased from 8.4% (95% CI: 7.8‐9.0) in 1996 to 9.9% (95% CI: 9.2‐10.6) in 2006 and 10.9% (95% CI: 10.1‐11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5‐5.5) in 1996 to 6.0% (95% CI: 5.4‐6.6) in 2006 and further to 7.3% (95% CI: 6.6‐8.0) in 2016 (P<.001), while the prevalence of non‐allergic asthma remained stable around 3.4%‐3.8%. The increase in current asthma was most pronounced among women and among the middle‐aged. Physician‐diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016. Conclusions and Clinical Relevance The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non‐allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking. Objective The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016. Methods Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma. Results The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 ( P <.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 ( P <.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016. Conclusions and Clinical Relevance The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. Background: During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking. Objective: The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016. Methods: Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma. Results: The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016. Conclusions and clinical relevance: The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.Three cross-sectional samples from the same area of Sweden, 20-69years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. Summary Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking. Objective The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016. Methods Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma. Results The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016. Conclusions and Clinical Relevance The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.BACKGROUNDDuring the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.OBJECTIVEThe aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.METHODSThree cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.RESULTSThe prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing.CONCLUSIONS AND CLINICAL RELEVANCEThe prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing. |
| Author | Stridsman, Caroline Andersson, Martin Rönmark, Eva Hedman, Linnea Backman, Helena Räisänen, Petri Lundbäck, Bo Lindberg, Anne |
| Author_xml | – sequence: 1 givenname: Helena orcidid: 0000-0002-0553-8067 surname: Backman fullname: Backman, Helena email: helena.backman@nll.se organization: Umeå University – sequence: 2 givenname: Petri surname: Räisänen fullname: Räisänen, Petri organization: Umeå University – sequence: 3 givenname: Linnea surname: Hedman fullname: Hedman, Linnea organization: Luleå University – sequence: 4 givenname: Caroline surname: Stridsman fullname: Stridsman, Caroline organization: Luleå University – sequence: 5 givenname: Martin surname: Andersson fullname: Andersson, Martin organization: Umeå University – sequence: 6 givenname: Anne surname: Lindberg fullname: Lindberg, Anne organization: Umeå University – sequence: 7 givenname: Bo surname: Lundbäck fullname: Lundbäck, Bo organization: University of Gothenburg – sequence: 8 givenname: Eva surname: Rönmark fullname: Rönmark, Eva organization: Umeå University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28608416$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-64044$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-140682$$DView record from Swedish Publication Index https://gup.ub.gu.se/publication/260647$$DView record from Swedish Publication Index |
| BookMark | eNqF0s1u1DAQAGALFdHtwoEXQJa4FIm0dvyT-Lha2lKpEhfgarnOZDeVEwc7brU3HoIn5EnwNqWHSpS5WBp9M5Y9c4QOBj8AQm8pOaE5Ti2YE1oqyV6gBWVSFGWOA7QgSvCiqhU_REcx3hBCmFD1K3RY1pLUnMoFSpeDDWAiNHgMcGscDBawb7FxDsKms9jEadsb3AbfY6qUxJPHJSESm6HBbQrTFsKco_L3z18BYnJTnP20DQB49GNyZur8gGMKt7CLr9HL1rgIbx7OJfp2fvZ1_bm4-nJxuV5dFVbIihWcAedMMdI2ArhSpqrBsJKrhhpDbUtrxmrgzPKyrLjgtiLKNELUvGlVzUu2RMXcN97BmK71GLrehJ32ptObNOqc2iQdQZeSSF496z9131fah41OfdKUE1nv-3_8v3dT0pKT_JIlOp75GPyPBHHSfRctOGcG8ClqqogqGauqfef3T-iNT2HIn5WVEEpVhJKs3j2odN1D83j_3_lm8GEGNvgYA7SPhBK93x2dd0ff7062p0-s7ab7sU3BdO65irvOwe7frfX6bDVX_AFH5dOo |
| CitedBy_id | crossref_primary_10_1080_02770903_2020_1728769 crossref_primary_10_1126_scisignal_abc9089 crossref_primary_10_1111_resp_14774 crossref_primary_10_7189_jogh_10_020409 crossref_primary_10_1186_s12890_023_02383_x crossref_primary_10_1007_s11869_021_01011_z crossref_primary_10_1159_000517201 crossref_primary_10_1002_hsr2_1015 crossref_primary_10_1038_s41598_019_41305_y crossref_primary_10_3389_fimmu_2020_01334 crossref_primary_10_1080_02770903_2021_1871742 crossref_primary_10_1093_ije_dyac197 crossref_primary_10_1371_journal_pone_0253322 crossref_primary_10_1016_j_rmr_2023_01_011 crossref_primary_10_3389_fcell_2021_648313 crossref_primary_10_1080_02770903_2021_1871741 crossref_primary_10_3390_allergies2020006 crossref_primary_10_2478_pneum_2019_0030 crossref_primary_10_1080_02770903_2020_1776727 crossref_primary_10_1016_j_intimp_2020_106243 crossref_primary_10_1016_j_resp_2020_103412 crossref_primary_10_1016_j_rmed_2019_09_013 crossref_primary_10_3390_jcm13185609 crossref_primary_10_1002_clt2_12013 crossref_primary_10_1183_23120541_00262_2021 crossref_primary_10_3390_children8030173 crossref_primary_10_1111_all_13840 crossref_primary_10_1111_all_15986 crossref_primary_10_1183_13993003_02476_2019 crossref_primary_10_1016_j_biopha_2021_111421 crossref_primary_10_33476_ms_v10i2_3962 crossref_primary_10_1097_ACI_0000000000000559 crossref_primary_10_1016_j_aller_2020_03_010 crossref_primary_10_1016_j_ssmph_2021_100741 crossref_primary_10_1038_s41598_019_55259_8 crossref_primary_10_1111_cea_13046 crossref_primary_10_1111_apa_15162 crossref_primary_10_1126_scitranslmed_add2563 crossref_primary_10_2147_JAA_S460051 crossref_primary_10_1038_s41577_021_00538_7 crossref_primary_10_1159_000525293 crossref_primary_10_1016_j_jaip_2023_05_034 crossref_primary_10_1136_bmjopen_2018_027808 crossref_primary_10_14341_omet10083 crossref_primary_10_1186_s12890_021_01664_7 crossref_primary_10_1016_j_rmed_2019_07_014 crossref_primary_10_2500_aap_2023_44_220077 crossref_primary_10_4168_aard_2018_6_2_90 crossref_primary_10_1177_03000605221109389 crossref_primary_10_1111_all_13971 crossref_primary_10_1016_j_rmed_2023_107192 crossref_primary_10_1016_j_envpol_2023_121716 crossref_primary_10_1007_s11682_021_00490_z crossref_primary_10_1111_cea_13711 crossref_primary_10_2500_aap_2022_43_210102 crossref_primary_10_1007_s11882_018_0766_x crossref_primary_10_1111_cea_13790 crossref_primary_10_1016_j_waojou_2021_100544 crossref_primary_10_1080_21505594_2021_1979812 crossref_primary_10_1111_ddg_15202_g crossref_primary_10_1007_s11356_022_19086_1 crossref_primary_10_1007_s40121_023_00902_1 crossref_primary_10_1016_j_freeradbiomed_2022_04_013 crossref_primary_10_1016_j_pharmthera_2022_108115 crossref_primary_10_1080_08820139_2025_2450239 crossref_primary_10_2478_cipms_2022_0009 crossref_primary_10_1183_23120541_00074_2022 crossref_primary_10_2174_1389203724666230303091754 crossref_primary_10_1080_20018525_2020_1833412 crossref_primary_10_1136_bmjopen_2020_040683 crossref_primary_10_3390_ijms241411273 crossref_primary_10_3390_medicina55060261 crossref_primary_10_1002_jat_4017 crossref_primary_10_1111_all_15885 crossref_primary_10_1111_all_14157 crossref_primary_10_1016_j_opresp_2023_100282 crossref_primary_10_1186_s12931_021_01669_0 crossref_primary_10_37349_eaa_2025_100967 crossref_primary_10_1016_j_ijbiomac_2024_137630 crossref_primary_10_1016_j_gendis_2019_03_006 crossref_primary_10_1186_s13287_020_02072_0 crossref_primary_10_1097_MD_0000000000039840 crossref_primary_10_1111_jth_15302 crossref_primary_10_1183_13993003_00826_2023 crossref_primary_10_1007_s00420_021_01694_y crossref_primary_10_1080_02770903_2020_1713150 crossref_primary_10_1183_13993003_03200_2021 crossref_primary_10_18332_tid_176949 crossref_primary_10_1186_s12890_021_01529_z crossref_primary_10_3390_nu11122902 crossref_primary_10_3390_nu13103380 crossref_primary_10_1016_j_coi_2024_102494 crossref_primary_10_3389_fimmu_2024_1443166 crossref_primary_10_1016_j_waojou_2023_100805 crossref_primary_10_1111_imr_13191 crossref_primary_10_1001_jamanetworkopen_2018_0789 crossref_primary_10_1159_000494440 crossref_primary_10_21518_ms2023_400 crossref_primary_10_1111_all_13630 crossref_primary_10_1093_toxsci_kfaa168 crossref_primary_10_1038_s41598_021_93907_0 crossref_primary_10_1080_02770903_2022_2045310 crossref_primary_10_1016_j_amjmed_2025_01_005 crossref_primary_10_3389_fneur_2021_615820 crossref_primary_10_1016_j_anai_2020_03_010 crossref_primary_10_1111_cea_13378 crossref_primary_10_1016_j_peptides_2021_170628 crossref_primary_10_1055_s_0041_1732424 crossref_primary_10_1186_s12940_022_00871_x crossref_primary_10_1007_s00508_022_02081_4 crossref_primary_10_3389_fmed_2021_645356 crossref_primary_10_1111_imr_70012 crossref_primary_10_1016_j_tox_2024_153882 crossref_primary_10_2147_JAA_S450103 crossref_primary_10_1186_s12890_019_1040_2 crossref_primary_10_1016_j_mucimm_2024_02_001 crossref_primary_10_1016_j_rmed_2020_106250 crossref_primary_10_1159_000538597 crossref_primary_10_1016_j_jaci_2021_11_026 crossref_primary_10_1002_lary_29128 crossref_primary_10_1080_02770903_2023_2169933 crossref_primary_10_1186_s12967_024_05782_8 crossref_primary_10_1080_10408363_2022_2140329 crossref_primary_10_1111_cea_14616 crossref_primary_10_1152_ajplung_00269_2023 crossref_primary_10_29219_fnr_v66_8842 crossref_primary_10_1016_j_rmed_2021_106513 crossref_primary_10_1186_s12887_020_02077_x crossref_primary_10_3390_nu15204318 crossref_primary_10_1007_s00420_022_01884_2 crossref_primary_10_1016_j_rmed_2020_106017 crossref_primary_10_1080_02770903_2023_2231078 crossref_primary_10_1186_s12890_022_02230_5 crossref_primary_10_1152_physrev_00043_2022 crossref_primary_10_1186_s13601_019_0306_3 crossref_primary_10_1007_s12325_023_02647_2 crossref_primary_10_1089_ped_2017_0793 crossref_primary_10_33590_emjallergyimmunol_10312759 crossref_primary_10_1016_j_humgen_2023_201181 crossref_primary_10_1159_000504439 crossref_primary_10_1177_17534666211049738 crossref_primary_10_15616_BSL_2020_26_4_344 crossref_primary_10_33590_emjallergyimmunol_10311307 crossref_primary_10_1186_s12974_022_02575_y crossref_primary_10_1002_clt2_12374 crossref_primary_10_1097_CM9_0000000000001983 crossref_primary_10_4049_immunohorizons_2100107 crossref_primary_10_3389_fimmu_2024_1348305 crossref_primary_10_1002_tsm2_219 crossref_primary_10_1016_j_rmed_2019_06_003 crossref_primary_10_1080_20018525_2018_1468715 crossref_primary_10_1183_13993003_02130_2018 crossref_primary_10_2174_1386207325666220616124156 crossref_primary_10_1016_j_rmed_2024_107714 crossref_primary_10_1111_crj_12750 crossref_primary_10_1159_000513811 crossref_primary_10_1186_s40413_018_0184_5 crossref_primary_10_1016_j_opresp_2023_100245 crossref_primary_10_1016_j_rmed_2019_105860 crossref_primary_10_1177_0300060519899760 crossref_primary_10_1186_s12944_024_02179_w crossref_primary_10_61186_ismj_25_6_489 crossref_primary_10_1183_23120541_00620_2020 crossref_primary_10_1111_resp_14065 crossref_primary_10_1016_j_envpol_2024_124127 crossref_primary_10_1186_s12931_020_1308_3 crossref_primary_10_1080_02770903_2022_2039937 crossref_primary_10_3390_nu11092187 crossref_primary_10_1177_14034948211060821 crossref_primary_10_1111_ddg_15202 crossref_primary_10_1016_j_rmed_2023_107301 crossref_primary_10_1159_000525870 crossref_primary_10_1183_23120541_00258_2019 crossref_primary_10_1111_apa_16118 crossref_primary_10_1038_s41598_019_48305_y crossref_primary_10_2147_JIR_S471963 crossref_primary_10_1007_s10654_020_00646_z crossref_primary_10_1126_science_aba0864 crossref_primary_10_3389_fcell_2025_1563427 |
| Cites_doi | 10.1056/NEJMoa022363 10.1056/NEJMra054308 10.1111/j.1398-9995.2008.01886.x 10.1183/09031936.03.00056103 10.1111/all.12470 10.4104/pcrj.2013.00002 10.1111/j.1365-2222.1989.tb02345.x 10.1016/S0140-6736(97)07302-9 10.1136/thx.2006.066407 10.1034/j.1399-3003.1999.14d25.x 10.1136/thorax.55.10.833 10.1067/mai.2003.1484 10.1371/journal.pone.0016082 10.5694/j.1326-5377.2006.tb00207.x 10.1016/S0140-6736(02)09841-0 10.1016/j.jaci.2015.06.015 10.1136/bmj.38435.582975.AE 10.1136/bmj.38057.583727.47 10.1053/rmed.2001.1031 10.1183/09031936.00061611 10.1038/nm.2678 10.1186/1939-4551-7-1 10.1378/chest.119.3.852 10.1111/cea.12897 10.1016/j.rmed.2016.03.013 10.1111/j.1398-9995.2010.02533.x 10.1111/j.1365-2222.2004.01841.x 10.1186/1710-1492-9-20 10.1111/j.1398-9995.1997.tb00178.x 10.1111/cea.12757 10.1111/j.1365-2222.2006.02460.x 10.1186/1471-2458-12-204 10.1111/all.12397 10.1183/09031936.04.00074004 10.1016/j.jaip.2016.09.025 10.1111/j.1398-9995.2009.02105.x 10.1111/all.13053 10.1183/09031936.00194308 10.1111/cea.12544 10.1183/09031936.02.00822002 10.1183/09031936.00177908 10.1016/S0140-6736(15)00156-7 10.1016/j.rmed.2015.11.006 10.1136/bmj.312.7040.1195 10.1111/pai.12376 |
| ContentType | Journal Article |
| Copyright | 2017 The Authors. published by John Wiley & Sons Ltd 2017 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2017 The Authors. published by John Wiley & Sons Ltd – notice: 2017 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons Ltd |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 ADTPV AOWAS ADHXS D8T D93 ZZAVC AAOVB F1U |
| DOI | 10.1111/cea.12963 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic SwePub SwePub Articles SWEPUB Umeå universitet full text SWEPUB Freely available online SWEPUB Umeå universitet SwePub Articles full text SWEPUB Göteborgs universitet full text SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology Nursing |
| EISSN | 1365-2222 |
| EndPage | 1435 |
| ExternalDocumentID | oai_gup_ub_gu_se_260647 oai_DiVA_org_umu_140682 oai_DiVA_org_ltu_64044 28608416 10_1111_cea_12963 CEA12963 |
| Genre | article Historical Article Journal Article |
| GrantInformation_xml | – fundername: The Swedish Research Council – fundername: ALF – fundername: The Swedish Heart & Lung Foundation – fundername: Norrbotten County Council – fundername: The Swedish Asthma‐Allergy Foundation – fundername: Visare Norr |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 24P 29B 31~ 33P 36B 3O- 3SF 4.4 4P2 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBB EBC EBD EBS EBX EDH EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 ADTPV AOWAS ADHXS D8T D93 ZZAVC AAOVB F1U |
| ID | FETCH-LOGICAL-c5673-43e443930fd5e499a78ea3249d1aa1cf18338e43c4227454c709ad5584df98423 |
| IEDL.DBID | 24P |
| ISSN | 0954-7894 1365-2222 |
| IngestDate | Thu Aug 21 06:43:42 EDT 2025 Thu Aug 21 06:22:54 EDT 2025 Thu Aug 21 06:52:52 EDT 2025 Fri Jul 11 05:08:51 EDT 2025 Fri Jul 25 20:04:12 EDT 2025 Mon Jul 21 05:42:04 EDT 2025 Tue Jul 01 02:53:27 EDT 2025 Thu Apr 24 22:58:47 EDT 2025 Wed Jan 22 17:10:54 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | epidemiology asthma rhinitis |
| Language | English |
| License | Attribution-NonCommercial http://creativecommons.org/licenses/by-nc/4.0 2017 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5673-43e443930fd5e499a78ea3249d1aa1cf18338e43c4227454c709ad5584df98423 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0553-8067 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcea.12963 |
| PMID | 28608416 |
| PQID | 1955997010 |
| PQPubID | 36521 |
| PageCount | 10 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_260647 swepub_primary_oai_DiVA_org_umu_140682 swepub_primary_oai_DiVA_org_ltu_64044 proquest_miscellaneous_1909233772 proquest_journals_1955997010 pubmed_primary_28608416 crossref_primary_10_1111_cea_12963 crossref_citationtrail_10_1111_cea_12963 wiley_primary_10_1111_cea_12963_CEA12963 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | November 2017 |
| PublicationDateYYYYMMDD | 2017-11-01 |
| PublicationDate_xml | – month: 11 year: 2017 text: November 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | Clinical and experimental allergy |
| PublicationTitleAlternate | Clin Exp Allergy |
| PublicationYear | 2017 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2017; 5 2010; 14 2010; 35 2009; 64 2013; 22 2005; 330 2017; 47 2015; 386 2004; 23 2006; 36 2014; 69 2012; 18 2012; 39 2004; 328 2012; 12 2011; 6 2003; 111 1998; 351 2013; 9 2006; 355 2009; 34 2017; 72 2015; 45 2015; 26 2010; 65 2003; 349 2002; 164 2002; 20 2002; 360 2015; 136 1997; 52 2000; 55 2004; 34 1999; 14 2006; 184 2011; 66 2016; 110 2007; 62 2013 2016; 114 2001; 119 1996; 312 2014; 7 2001; 95 1989; 19 2003; 21 2016; 46 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 e_1_2_8_19_1 Linneberg AR (e_1_2_8_34_1) 2002; 164 e_1_2_8_13_1 e_1_2_8_36_1 Lundbäck B (e_1_2_8_22_1) 2015; 26 e_1_2_8_15_1 e_1_2_8_38_1 Ekerljung L (e_1_2_8_14_1) 2010; 14 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_40_1 e_1_2_8_18_1 e_1_2_8_39_1 Gibson J (e_1_2_8_3_1) 2013 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_50_1 |
| References_xml | – volume: 330 start-page: 1187 year: 2005 end-page: 1188 article-title: Changes in atopy over a quarter of a century, based on cross sectional data at three time periods publication-title: BMJ – volume: 110 start-page: 58 year: 2016 end-page: 65 article-title: Respiratory symptoms/diseases prevalence is still increasing: a 25‐yr population study publication-title: Respir Med – volume: 136 start-page: 1559 year: 2015 end-page: 1565 article-title: Allergic sensitization is age‐dependently associated with rhinitis, but less so with asthma publication-title: J Allergy Clin Immunol. – volume: 45 start-page: 1673 year: 2015 end-page: 1680 article-title: Dietary patterns and asthma prevalence, incidence and control publication-title: Clin Exp Allergy – volume: 66 start-page: 886 year: 2011 end-page: 892 article-title: Allergy gap between Finnish and Russian Karelia on increase publication-title: Allergy – volume: 95 start-page: 258 year: 2001 end-page: 264 article-title: Secular trends of allergic asthma in Danish adults. The Copenhagen Allergy Study publication-title: Respir Med – volume: 52 start-page: 1071 year: 1997 end-page: 1078 article-title: Incidence of asthma in adults–report from the Obstructive Lung Disease in Northern Sweden Study publication-title: Allergy – volume: 349 start-page: 1414 year: 2003 end-page: 1422 article-title: A longitudinal, population‐based, cohort study of childhood asthma followed to adulthood publication-title: N Engl J Med – volume: 12 start-page: 204 year: 2012 article-title: Global asthma prevalence in adults: findings from the cross‐sectional world health survey publication-title: BMC Public Health – volume: 62 start-page: 85 year: 2007 end-page: 90 article-title: 50 years of asthma: UK trends from 1955 to 2004 publication-title: Thorax – volume: 20 start-page: 826 year: 2002 end-page: 833 article-title: Apparent but not real increase in asthma prevalence during the 1990s publication-title: Eur Respir J – volume: 360 start-page: 691 year: 2002 end-page: 692 article-title: Frequency of atopy in the Arctic in 1987 and 1998 publication-title: Lancet – volume: 55 start-page: 833 year: 2000 end-page: 836 article-title: Increase in prevalence and severity of asthma in young adults in Copenhagen publication-title: Thorax – volume: 34 start-page: 38 year: 2004 end-page: 43 article-title: Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non‐farming environments. A nationwide study over three decades publication-title: Clin Exp Allergy – volume: 351 start-page: 1225 year: 1998 end-page: 1232 article-title: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee publication-title: Lancet. – volume: 114 start-page: 103 year: 2016 end-page: 110 article-title: Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden publication-title: Respir Med – volume: 164 start-page: 4061 year: 2002 end-page: 4065 article-title: Increasing prevalence of specific IgE against aeroallergens in an adult Danish population–two cross‐sectional studies in 1990 and 1998 publication-title: Ugeskr Laeger – volume: 69 start-page: 1275 year: 2014 end-page: 1279 article-title: Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review publication-title: Allergy – volume: 26 start-page: 367 year: 2015 end-page: 374 article-title: Time trends in the incidence, prevalence and age at diagnosis of asthma in children publication-title: Pediatr Allergy Immunol – volume: 5 start-page: 457 year: 2017 end-page: 463 article-title: Increase in Allergic Sensitization in Schoolchildren: two Cohorts Compared 10 Years Apart publication-title: J Allergy Clin Immunol Pract. – volume: 312 start-page: 1195 year: 1996 end-page: 1199 article-title: Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort publication-title: BMJ – volume: 386 start-page: 1075 year: 2015 end-page: 1085 article-title: Risk factors for asthma: is prevention possible? publication-title: Lancet – volume: 111 start-page: 1232 year: 2003 end-page: 1238 article-title: Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study publication-title: J Allergy Clin Immunol – volume: 328 start-page: 1052 year: 2004 end-page: 1053 article-title: Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12‐14 year olds in the British Isles, 1995‐2002: questionnaire survey publication-title: BMJ – volume: 19 start-page: 59 year: 1989 end-page: 63 article-title: Asthma and allergic rhinitis in Swedish conscripts publication-title: Clin Exp Allergy – volume: 14 start-page: 764 year: 2010 end-page: 771 article-title: Has the increase in the prevalence of asthma and respiratory symptoms reached a plateau in Stockholm, Sweden? publication-title: Int J Tuberc Lung Dis – volume: 36 start-page: 503 year: 2006 end-page: 509 article-title: Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland publication-title: Clin Exp Allergy – volume: 26 start-page: 1 year: 2015 end-page: 13 article-title: Is asthma prevalence still increasing? publication-title: Expert Rev Respir Med – volume: 119 start-page: 852 year: 2001 end-page: 861 article-title: Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study publication-title: Chest – volume: 65 start-page: 48 year: 2010 end-page: 55 article-title: Time trends in asthma and wheeze in Swedish children 1996‐2006: prevalence and risk factors by sex publication-title: Allergy – volume: 69 start-page: 643 year: 2014 end-page: 651 article-title: Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey publication-title: Allergy – volume: 9 start-page: 20 year: 2013 article-title: Increase in sensitization to common airborne allergens among adults ‐ two population‐based studies 15 years apart publication-title: Allergy Asthma Clin Immunol. – volume: 355 start-page: 2226 year: 2006 end-page: 2235 article-title: The asthma epidemic publication-title: N Engl J Med – volume: 7 start-page: 1 year: 2014 article-title: Prevalence trends in respiratory symptoms and asthma in relation to smoking ‐ two cross‐sectional studies ten years apart among adults in northern Sweden publication-title: World Allergy Organ J. – volume: 39 start-page: 883 year: 2012 end-page: 892 article-title: Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010 publication-title: Eur Respir J – volume: 64 start-page: 798 year: 2009 end-page: 800 article-title: Time trends in prevalence and severity of childhood asthma and allergies from 1995 to 2002 in France publication-title: Allergy – volume: 184 start-page: 226 year: 2006 end-page: 229 article-title: Trends in asthma prevalence and population changes in South Australia, 1990‐2003 publication-title: Med J Aust. – volume: 14 start-page: 876 year: 1999 end-page: 884 article-title: Sensitization to individual allergens and bronchial responsiveness in the ECRHS. European Community Respiratory Health Survey publication-title: Eur Respir J – volume: 35 start-page: 273 year: 2010 end-page: 278 article-title: Changes in the prevalence of asthma in adults since 1966: the Busselton health study publication-title: Eur Respir J – volume: 72 start-page: 723 year: 2017 end-page: 730 article-title: High incidence and persistence of airborne allergen sensitization up to age 19 years publication-title: Allergy – volume: 21 start-page: 468 year: 2003 end-page: 472 article-title: Long‐term changes in adult asthma prevalence publication-title: Eur Respir J – volume: 47 start-page: 520 year: 2017 end-page: 529 article-title: The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study publication-title: Clin Exp Allergy – volume: 23 start-page: 407 year: 2004 end-page: 413 article-title: No further increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland publication-title: Eur Respir J – volume: 34 start-page: 1046 year: 2009 end-page: 1051 article-title: Prevalence and severity of self‐reported asthma in young adults, 1976‐2004 publication-title: Eur Respir J – volume: 46 start-page: 1328 year: 2016 end-page: 1336 article-title: Increase in pollen sensitization in Swedish adults and protective effect of keeping animals in childhood publication-title: Clin Exp Allergy – volume: 18 start-page: 716 year: 2012 end-page: 725 article-title: Asthma phenotypes: the evolution from clinical to molecular approaches publication-title: Nat Med – volume: 6 start-page: e16082 year: 2011 article-title: Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA(2)LEN surveys publication-title: PLoS One – year: 2013 – volume: 22 start-page: 64 year: 2013 end-page: 71 article-title: Increase in prevalence of physician‐diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross‐sectional cohort study publication-title: Prim Care Respir J – volume: 14 start-page: 764 year: 2010 ident: e_1_2_8_14_1 article-title: Has the increase in the prevalence of asthma and respiratory symptoms reached a plateau in Stockholm, Sweden? publication-title: Int J Tuberc Lung Dis – ident: e_1_2_8_5_1 doi: 10.1056/NEJMoa022363 – ident: e_1_2_8_20_1 doi: 10.1056/NEJMra054308 – ident: e_1_2_8_21_1 doi: 10.1111/j.1398-9995.2008.01886.x – volume-title: The European Lung White Book year: 2013 ident: e_1_2_8_3_1 – ident: e_1_2_8_11_1 doi: 10.1183/09031936.03.00056103 – ident: e_1_2_8_8_1 doi: 10.1111/all.12470 – ident: e_1_2_8_25_1 doi: 10.4104/pcrj.2013.00002 – ident: e_1_2_8_45_1 doi: 10.1111/j.1365-2222.1989.tb02345.x – ident: e_1_2_8_17_1 doi: 10.1016/S0140-6736(97)07302-9 – ident: e_1_2_8_24_1 doi: 10.1136/thx.2006.066407 – ident: e_1_2_8_28_1 doi: 10.1034/j.1399-3003.1999.14d25.x – ident: e_1_2_8_7_1 doi: 10.1136/thorax.55.10.833 – ident: e_1_2_8_48_1 doi: 10.1067/mai.2003.1484 – ident: e_1_2_8_27_1 doi: 10.1371/journal.pone.0016082 – ident: e_1_2_8_12_1 doi: 10.5694/j.1326-5377.2006.tb00207.x – ident: e_1_2_8_39_1 doi: 10.1016/S0140-6736(02)09841-0 – ident: e_1_2_8_43_1 doi: 10.1016/j.jaci.2015.06.015 – ident: e_1_2_8_33_1 doi: 10.1136/bmj.38435.582975.AE – ident: e_1_2_8_18_1 doi: 10.1136/bmj.38057.583727.47 – ident: e_1_2_8_23_1 doi: 10.1053/rmed.2001.1031 – ident: e_1_2_8_15_1 doi: 10.1183/09031936.00061611 – ident: e_1_2_8_9_1 doi: 10.1038/nm.2678 – ident: e_1_2_8_16_1 doi: 10.1186/1939-4551-7-1 – ident: e_1_2_8_35_1 doi: 10.1378/chest.119.3.852 – ident: e_1_2_8_44_1 doi: 10.1111/cea.12897 – ident: e_1_2_8_26_1 doi: 10.1016/j.rmed.2016.03.013 – ident: e_1_2_8_40_1 doi: 10.1111/j.1398-9995.2010.02533.x – ident: e_1_2_8_47_1 doi: 10.1111/j.1365-2222.2004.01841.x – ident: e_1_2_8_31_1 doi: 10.1186/1710-1492-9-20 – volume: 26 start-page: 1 year: 2015 ident: e_1_2_8_22_1 article-title: Is asthma prevalence still increasing? publication-title: Expert Rev Respir Med – ident: e_1_2_8_51_1 doi: 10.1111/j.1398-9995.1997.tb00178.x – ident: e_1_2_8_32_1 doi: 10.1111/cea.12757 – ident: e_1_2_8_42_1 doi: 10.1111/j.1365-2222.2006.02460.x – ident: e_1_2_8_2_1 doi: 10.1186/1471-2458-12-204 – ident: e_1_2_8_41_1 doi: 10.1111/all.12397 – ident: e_1_2_8_19_1 doi: 10.1183/09031936.04.00074004 – ident: e_1_2_8_30_1 doi: 10.1016/j.jaip.2016.09.025 – ident: e_1_2_8_50_1 doi: 10.1111/j.1398-9995.2009.02105.x – ident: e_1_2_8_29_1 doi: 10.1111/all.13053 – ident: e_1_2_8_13_1 doi: 10.1183/09031936.00194308 – volume: 164 start-page: 4061 year: 2002 ident: e_1_2_8_34_1 article-title: Increasing prevalence of specific IgE against aeroallergens in an adult Danish population–two cross‐sectional studies in 1990 and 1998 publication-title: Ugeskr Laeger – ident: e_1_2_8_37_1 doi: 10.1111/cea.12544 – ident: e_1_2_8_38_1 – ident: e_1_2_8_10_1 doi: 10.1183/09031936.02.00822002 – ident: e_1_2_8_46_1 doi: 10.1183/09031936.00177908 – ident: e_1_2_8_36_1 doi: 10.1016/S0140-6736(15)00156-7 – ident: e_1_2_8_49_1 doi: 10.1016/j.rmed.2015.11.006 – ident: e_1_2_8_4_1 doi: 10.1136/bmj.312.7040.1195 – ident: e_1_2_8_6_1 doi: 10.1111/pai.12376 |
| SSID | ssj0003598 |
| Score | 2.5964842 |
| Snippet | Summary
Background
During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma... During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends... Summary Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma... Background During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma... Background: During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma... |
| SourceID | swepub proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1426 |
| SubjectTerms | Adult Aged Allergic diseases Asthma Asthma - epidemiology Asthma - history Conjunctivitis Cross-Sectional Studies epidemiology Female Health Science History, 20th Century History, 21st Century Humans Hälsovetenskap Lungmedicin och allergi Male Middle Aged Mucous membrane Nursing Omvårdnad Population Surveillance Prevalence Respiratory Medicine and Allergy rhinitis Risk Factors Smoking Socioeconomic Factors Sweden - epidemiology Trends Young Adult |
| Title | Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016—results from three population surveys |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcea.12963 https://www.ncbi.nlm.nih.gov/pubmed/28608416 https://www.proquest.com/docview/1955997010 https://www.proquest.com/docview/1909233772 https://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-64044 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-140682 https://gup.ub.gu.se/publication/260647 |
| Volume | 47 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1da9VAEB1qRfFFav2KtrKKii-RJLvZZPHp0g-KUBGx0rdlb7K5CrfJJckW-uaP8Bf6S5xJcpeWVvElhGRCSCZn9kx25wzA66jgyuYqChVy0VBkpQnnMY_DJI8wJPMkNUNV2vEneXQiPp6mpxvwYV0LM-pD-B9uhIwhXhPAzby7BPLCmvc4WEl-C25TaS21L0jEZx-GSZpuFNoTYZYrMckK0TIef-nVwegaw_TyoVeZ6zD0HG7B_Ykzstno5AewYettuDN2kbzYhrvH0_z4Q3AId1plbku2aknIm3DLmopRx5QWgxwzXf_9zDCqKmG0NJj1DaN8n5m6ZJVriQ-Ox2L5--cvTMbdsu9G-x79btnKt_xinWvP8Ut4BCeHB1_3jsKpsUJYpDLjoeBWIBHhUVWmFlMe9Ic1yKxUGRsTFxXCnOdW8EIkmLSmosgiZcoUuUpZqRwJ2GPYrJvaPgVG6j95SqJAqhR5XBm8QGLwTdPE2kqaAN6t37AuJtVxan6x1OvsA52hB2cE8MqbrkapjZuMdtZu0hPaOh2TjJ7KMLUM4KU_jTihyQ9T28aRTYRclmMyEcCT0b3-LkkuI5p-DeDN6G9_hsS39398m-mmXehl77QUkRABvP2XnTtzmFFFMk9uNly4lcZDC6c7qzGflCLD1zR8YH9_cL13MBt2nv2_6XO4lxALGUond2Czb53dRQ7Vz18MWMHt_pfkD2nGFco |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB2VIigXBAVKoIBBgLgEJfFHEqmXVWm1QLfi0KLeLDdxFqRtskpiJG78CH5hf0lnkmzUioK4Rc5YUTKe8Xux_QbgdZDx1CZp4KeIRX0R58Y_DXnoR0mAKZlH0nSn0maHanosPp3IkzXYWZ2F6fUhxh9uFBldvqYApx_Sl6I8s-Y9zlaK34CbAnE5jelIfBnzMGnT9Up7wo-TVAy6QrSPZ-x6dTb6A2KO-qFXoWs39-zfg7sDaGST3sv3Yc2Wm3CrLyP5cxNuz4YF8gfgMN5pm7nN2bImJW8KXFYVjEqm1JjlmGnab2eG0bESRnuDWVsxIvzMlDkrXE2AsG8L1fmv38jG3aJtevsWHW_Zcqz5xRpX_8Ch8BCO9_eOdqf-UFnBz6SKuS-4FYhEeFDk0iLnQYdYg9AqzUNjwqzAOOeJFTwTEbJWKbI4SE0uEazkRZogAnsE62VV2sfASP4nkaQKlOYiCQuDHRRmXykjawtlPHi3-sI6G2THqfrFQq_oBzpDd87w4NVouuy1Nq4z2l65SQ_h1uiQdPTSGLmlBy_H2xgotPphSls5sgkQzHJkEx5s9e4dnxIlKqD1Vw_e9P4e75D69ofvXye6qud60TqtRCCEB2__ZefOHFKqQCXR9YZzt9TYNHe6sRoJpRIxfqZugP39xfXu3qS7ePL_pi9gY3o0O9AHHw8_P4U7EUGS7hzlNqy3tbPPEFC1p8-7uLkA8_QYVg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VIipeuJRboIBBgHjJKomdm3hadbsql1YIUdQHJMubOEvVbRIlMRI88RF8IV_CTG5QKAjxFjljJXFmxuck9hmAR07CYx3Fjh0jFrVFmCp74XLX9iIHUzL3fNXuStvbD3YPxItD_3ANng17YTp9iPGDG0VGm68pwMs0-ynIE60mOFkF_BycF4ETEfOavfmhHUXSdJ3QnrDDKBa9rBAt4xm7np6MfkOYo3zoaeTaTj3zy_B-uOluxcnxxDSLSfL5Fz3H_3yqK3Cph6Rs2vnQVVjT-SZc6IpUftqEjb3-9_s1MJhNaBG7TllZkU44pQVWZIwKslSYQ5mqmw8nitGmFUYrj1lTMPqcwFSessxUBDe7Njf49uUrcn2zaurOvkG30qwcK4qx2lQf0dGuw8F85-32rt3XbbATPwi5LbgWiHO4k6W-RkaFr1srBG5x6irlJhlmER5pwRPhISf2RRI6sUp9hEJpFkeI727Ael7k-hYwEheKfNIcilMRuZnCDgHmdt_3tM4CZcHT4QXKpBc1p9oaKzmQGxxQ2Q6oBQ9H07JT8jjLaGvwAtkHcy1dUumLQ2SuFjwYT2MY0r8VlevCkI2DUJkjV7HgZuc941W8CN0Tga8Fjzt3Gs-Qtvfs6N1UFtVSrhojA-EIYcGTv9mZE4OEzQki72zDpSklNi2NrLVEuhqIEIepdbo_P7jc3pm2B7f_3fQ-bLyezeWr5_sv78BFj_BOu0lzC9abyui7iNaaxb02Kr8DxRE3qA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+prevalence+of+allergic+asthma+from+1996+to+2006+and+further+to+2016%E2%80%94results+from+three+population+surveys&rft.jtitle=Clinical+and+experimental+allergy&rft.au=Backman%2C+Helena&rft.au=R%C3%A4is%C3%A4nen%2C+Petri&rft.au=Hedman%2C+Linnea&rft.au=Stridsman%2C+Caroline&rft.date=2017-11-01&rft.issn=0954-7894&rft.eissn=1365-2222&rft.volume=47&rft.issue=11&rft.spage=1426&rft.epage=1435&rft_id=info:doi/10.1111%2Fcea.12963&rft.externalDBID=10.1111%252Fcea.12963&rft.externalDocID=CEA12963 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-7894&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-7894&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-7894&client=summon |